| View |
|
DRP-2122-04
|
Guafenesin+Salbutamol (As Sulfate)
|
Bronc-Heal
|
100 mg/2mg
|
Capsule
|
Expectorant/Bronchodilator
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
26 May 2022
|
12 July 2027
|
| View |
|
DRP-2122
|
Guaifenesin + Salbutamol (As Sulfate)
|
Nassavent
|
100 mg/2 mg
|
Capsule
|
Expectorant/Bronchodilator
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
20 May 2022
|
12 July 2027
|
| View |
|
DRP-2122-01
|
Guaifenesin + Salbutamol (As Sulfate)
|
Asmaclear
|
100 mg/2 mg
|
Capsule
|
Expectorant/Bronchodilator
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
31 May 2022
|
12 July 2027
|
| View |
DR-XY37203_PI_01.pdf
|
DR-XY37203
|
Loteprednol Etabonate
|
Lotemax
|
5 mg/mL (0.5% w/v)
|
Ophthalmic Suspension
|
Corticosteroid
|
Bausch & Lomb, Inc.
|
United States of America
|
Initial (from Monitored Release) correction
|
13 October 2022
|
11 December 2024
|
| View |
|
DRP-1217-07
|
Amoxicillin (As Trihydrate)
|
None
|
100 mg/mL
|
Powder For Suspension (Oral Drops)
|
ANTIBACTERIAL (PENICILLIN)
|
J.M Tollman Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
15 July 2022
|
28 June 2027
|
| View |
|
DRP-3183
|
Losartan Potassium
|
Lipewin
|
50mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blockers (ARBs)
|
XL Laboratories Pvt. Ltd.
|
India
|
-
|
22 January 2022
|
07 June 2027
|
| View |
|
DRP-3183-02
|
Losartan Potassium
|
None
|
50mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blockers (ARBs)
|
XL Laboratories Pvt. Ltd.
|
India
|
Automatic Renewal
|
08 March 2022
|
07 June 2027
|
| View |
|
DR-XY28370
|
Amikacin (as sulfate)
|
None
|
250mg/mL (500mg/2mL)
|
Solution For Injection (IM/IV)
|
Antibacterial
|
Atlantic Laboratories Corp. Ltd.
|
Thailand
|
Automatic Renewal
|
11 February 2023
|
03 March 2028
|
| View |
|
DRP-2251-05
|
Loratadine
|
Prevahist
|
10 mg
|
Tablet
|
Antihistamine
|
XL Laboratories Pvt. Ltd.
|
India
|
Renewal
|
13 March 2024
|
01 December 2029
|
| View |
|
DRP-4366-02
|
Esomeprazole (as magnesium trihydrate)
|
Nuloc-O
|
40mg
|
Enteric Coated-Tablet
|
Proton Pump Inhibitor
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Automatic Renewal
|
12 June 2023
|
13 September 2028
|
| View |
|
DRP-10744
|
Domperidone
|
Motinorm
|
1 mg/mL (5 mg/5 mL)
|
Syrup
|
Propulsive
|
Medley Pharmaceuticals Limited
|
India
|
Initial (Variation) (Correction)
|
31 July 2024
|
01 August 2029
|
| View |
|
DRP-5806-11
|
Amlodipine (as Besilate)
|
Regivasc
|
5 mg
|
Tablet
|
Calcium Channel Blocker
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Renewal
|
02 November 2024
|
14 November 2029
|
| View |
|
DRP-5800-13
|
Amlodipine (as Besilate)
|
Regivasc
|
10 mg
|
Tablet
|
Calcium Channel Blocker
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Renewal
|
02 November 2024
|
14 November 2029
|
| View |
|
DRP-2751-07
|
Nifedipine
|
None
|
5 mg
|
Softgel Capsule
|
Calcium Channel Blocker
|
J.B. Chemicals & Pharmaceuticals Ltd.
|
India
|
Automatic Renewal
|
27 July 2023
|
03 August 2028
|
| View |
|
DRP-9333-01
|
5.4% Amino Acids
|
Aminovit
|
Formulation: Each mL contains: L-Leucine L-Methionine L-Phenylalanine L-Lysine Acetate (as L-Lysine) L-Valine
8.8 mg 8.8 mg 8.8 mg 6.4 mg 6.4 mg
L-Isoleucine L-Threonine L-Histidine L-Tryptophan L-Cysteine Hydrochloride
5.6 mg
4 mg 2.5 mg
2 mg 200 mcg
|
Solution for IV Infusion
|
Parenteral Nutrition
|
Dai Han Pharma. Co., Ltd.
|
Korea
|
Renewal
|
09 November 2024
|
20 November 2029
|
| View |
|
BRP-041-16
|
Enoxaparin Sodium
|
Noxaclane
|
4000 IU anti-Factor Xa (equivalent to 40 mg)/0.4 mL
|
Solution For Injection (Sc)
|
-
|
Brawn Laboratories Ltd.
|
India
|
-
|
18 April 2022
|
09 December 2025
|
| View |
|
BRP-040-15
|
Enoxaparin Sodium
|
Noxaclane
|
6000 IU anti-Factor Xa (equivalent to 60 mg)/0.6 mL
|
Solution For Injection (Sc)
|
Antithrombotic agents
|
Brawn Laboratories Ltd.
|
India
|
Initial (Reconstruction)
|
06 August 2024
|
09 December 2025
|
| View |
|
DRP-4061-04
|
Multivitamins + Dextrose
|
Vitagua
|
Formulation: Each 500 ml. Contains
Dextrose-25 mg D-Panthenol-250mg Ascorbic Acid (Vitamin C)-500mg Thiamine HCl (Vitamin B1)-125mg
Riboflavin (Vitamin B2)-25mg Pyridoxine HCI (Vitamin B6)-25mg Nicotinamide-625mg
|
Solution For Injection (IV)
|
-
|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
|
China
|
-
|
17 November 2021
|
14 June 2026
|
| View |
|
DRP-3108-06
|
Amlodipine (As Besilate)
|
Ivatrol
|
10 mg
|
Tablet
|
-
|
Scheele Laboratories Phils., Inc.
|
Philippines
|
-
|
17 November 2021
|
08 July 2026
|
| View |
|
DRP-5279-04
|
Montelukast (as sodium)
|
Monteraph
|
10 mg
|
Tablet
|
Leukotriene Receptor Antagonist
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Renewal
|
06 May 2024
|
24 April 2029
|